Novel extracorporeal device 'amytrapper' to remove beta amyloid in alzheimer's disease

Active Project Grant Awarded Last action

Award ID
R44AG057327
Recipient
Awarding agency
Obligated
$6,493,315

Award facts

Assistance listing
93.866 Aging Research
Completion date 94% complete
Originally
Place of performance
Cheshire, CT 06410, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $625,405
Amendment $625,405
Amendment $784,203
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $806,673
Amendment $806,673
Amendment $806,673
Amendment $806,673
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $592,009
Amendment $0
Amendment $0
Amendment $164,780
Original award $474,821
Show all 29

Quick answers

Who received award R44AG057327?

R44AG057327 was awarded to Recombinant Technologies LLC by National Institute on Aging (National Institutes of Health) on August 2, 2019.

How much is award R44AG057327 worth?

$6,493,315 has been obligated on R44AG057327.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award